Monthly, quarterly and annual GLP-1 plans

Tonik Wellness review

Tonik makes the prepaid bill unusually clear: semaglutide is $495 quarterly or $1,788 annually, versus a $225 monthly option. Tirzepatide has separate prices and possible higher-dose upgrades. The drawback is flexibility: month-to-month marketing conflicts with the three-month subscription policy.

Check your care options.

Confirm the medication, clinical access and recurring bill for your own plan.

Visit Tonik WellnessOfficial provider website. No affiliate relationship is currently listed.

A fit for

Self-pay readers comparing documented plan invoices who can resolve clinical scope, dose-related pricing and the cancellation agreement.

  • Quarterly and annual cards show the amount actually billed.
  • Both medication plan selections list supplies and provider oversight.
  • The expanded care panel describes continuing check-ins and adjustments.

Tradeoffs to understand

Buyers treating $149 as a monthly semaglutide charge or assuming the advertised monthly plan guarantees a one-month exit.

  • Annual equivalents require substantial upfront payment.
  • Monthly flexibility language conflicts with the subscription minimum.
  • Higher-dose tirzepatide may need an upgraded plan.
In this review

The annual equivalent is not the monthly bill

Tonik’s semaglutide cards show $225 monthly, $495 every three months and $1,788 billed yearly. The latter two are displayed as $165 and $149 monthly equivalents. The product page’s $149 start therefore needs its annual payment condition attached. It is not an offer to pay $149 each month. [1] [2]

The selected tirzepatide plans show $349 monthly, $747 quarterly and $2,748 yearly, with $249 and $229 equivalents. A note says higher-dose protocols may require an upgraded plan. Confirm the actual prescribed plan, invoice and supplied calendar; an annual payment label does not establish that twelve months of medication ship together. [1]

Clinical access is described more clearly than every fee

The plan cards include medication, injection supplies, provider oversight, concierge support and a secure portal. The expanded included-care panel adds provider evaluation, continuing check-ins, adjustments and access to metabolic support and coaching. Those features make Tonik worth comparing when organized prescription follow-up is the need. [1]

The pages do not establish a guaranteed response time, a set number of coaching appointments or every included laboratory test. A free introduction is described as matching the reader with a concierge. Separate that from the prescribing assessment and get any clinical or lab charges added to the total, despite the care-model page’s conflicting membership descriptions. [2] [3]

The monthly option needs its own exit agreement

The monthly plan says month-to-month access. The medication policy nevertheless requires an initial three-month subscription period. It allows written cancellation before the next bill, but the general terms separately require thirty days before the next monthly processing date after the commitment. Resolve those differences before choosing the supposedly flexible option. [1] [4] [5]

A refill already ordered from the pharmacy can still be billed. Processed subscription cycles have no partial refund; clinical fees become nonrefundable when service is rendered or intake review starts. Medication orders are nonrefundable once placed with the pharmacy. These are purchase boundaries, not a guaranteed eligibility refund or a trial period. [4]

Compounded semaglutide is a distinct product question

Tonik explicitly describes its semaglutide as compounded. Its weight-loss percentage claims do not prove the result of this preparation or predict an individual’s outcome. Compounded products are not FDA-approved, and personalization alone does not establish equivalence to a branded trial medicine. [2] [6]

Current FDA guidance also distinguishes patient-specific compounding conditions after shortage resolution. A catalogue listing is not proof of the legal basis or quality of an individual order. Confirm the actual prescription and dispenser with the provider. For damage, wrong medication or missing items, Tonik requires contact within forty-eight hours of delivery with photographs. [4] [5] [7]

Understanding the cost

Semaglutide $225 monthly/$495 quarterly ($165 equivalent)/$1,788 yearly ($149 equivalent). Selected tirzepatide $349 monthly/$747 quarterly ($249 equivalent)/$2,748 yearly ($229 equivalent); higher-dose protocols may require upgrade. Actual first invoice, formulation, laboratory charges and exit terms still need confirmation.

Build your cost estimate

Sources

  1. Tonik: selected semaglutide and tirzepatide plans and expanded included-care panel
  2. Tonik: compounded injectable semaglutide description
  3. Tonik: concierge and provider access with conflicting membership descriptions
  4. Tonik: subscription minimum, prescription final sale and delivery reporting
  5. Tonik: provider and pharmacy roles, billing and cancellation notice
  6. FDA: compounded drugs and premarket review limits
  7. FDA: current GLP-1 compounding conditions after shortage resolution

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.